| Sources | Names Used |
|---|---|
| GDSC1000 | MPS-1-IN-1 |
| PharmacoGx | MPS-1-IN-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CACNA2D3 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | CACNA2D4 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ACVR1B | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | SGCE | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | FUT7 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | GPLD1 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | ERC2 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | CD37 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-08 |
| mRNA | FIGLA | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | PFKFB3 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
